Policlinico Universitario Campus Bio Medico
About Policlinico Universitario Campus Bio Medico
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Italian Sarcoma Group
10
Campus Bio-Medico University
6
Pfizer
5
Celgene
4
Fondazione del Piemonte per l'Oncologia
4
International Extranodal Lymphoma Study Group (IELSG)
3
Janssen Research & Development, LLC
3
Shire
3
Amgen
2
Consorzio Oncotech
2
Fondazione Italiana Linfomi ONLUS
2
Clinical Trials at Policlinico Universitario Campus Bio Medico
During the past decade, Policlinico Universitario Campus Bio Medico conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 20 clinical trials were completed, i.e. on
average, 27.8% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 13 clinical trials were completed. i.e. 68.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma
2006-01-01
2013-09-01
Unknown status
399
Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma
2005-12-01
2014-03-01
Unknown status
534
Carotid Endarterectomy Versus Carotid Artery Stenting in Asymptomatic Patients
2008-01-01
2020-12-01
Unknown status
3,600
Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
2009-08-21
2018-06-28
Completed
479
Safety and Feasibility Study of Combination of State of Art Chemoimmunotherapy, Intensive Central Nervous System Prophylaxis and Scrotal Irradiation to Treat Primary Diffuse Large B-cell Lymphoma of Testis
2009-04-01
2023-12-01
Active, not recruiting
54
Evaluation of Long-term Prucalopride Treatment With Chronic Constipation in Subjects Aged ≥ 18 Years
2011-04-06
2012-12-19
Completed
364
Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma
2012-10-01
2029-12-17
Active, not recruiting
540
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Policlinico Universitario Campus Bio Medico" #1 sponsor was "Italian Sarcoma Group" with 10 trials, followed by "Campus Bio-Medico University" with 6 trials
sponsored, "Pfizer" with 5 trials sponsored, "Celgene" with 4 trials sponsored and "Fondazione del Piemonte per l'Oncologia"
with 4 trials sponsored. Other sponsors include 63 different institutions and
companies that sponsored additional 55 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinico Universitario Campus Bio Medico"
#1 collaborator was "PharmaMar" with 4 trials as a collaborator, "Clinical Research Technology S.r.l." with 2 trials as a collaborator, "Helsinn Healthcare SA" with 2 trials as a collaborator, "1Med" with 1 trials as a collaborator and "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were
collaborators in the rest 27 trials.
Clinical Trials Conditions at Policlinico Universitario Campus Bio Medico
According to Clinical.Site data, the most researched conditions in "Policlinico Universitario Campus Bio Medico" are
"Ulcerative Colitis" (5 trials), "Breast Cancer" (3 trials), "Advanced Cholangiocarcinoma" (2 trials), "Dedifferentiated Liposarcoma" (2 trials) and "Follicular Lymphoma" (2 trials). Many other conditions were trialed in "Policlinico Universitario Campus Bio Medico" in a lesser frequency.
Clinical Trials Intervention Types at Policlinico Universitario Campus Bio Medico
Most popular intervention types in "Policlinico Universitario Campus Bio Medico" are "Drug" (68 trials), "Procedure" (9 trials), "Other" (8 trials), "Device" (6 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Trabectedin" (6 trials), "Gemcitabine" (5 trials), "Cyclophosphamide" (3 trials) and "Rituximab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Policlinico Universitario Campus Bio Medico
The vast majority of trials in "Policlinico Universitario Campus Bio Medico" are
90 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Policlinico Universitario Campus Bio Medico
Currently, there are NaN active trials in "Policlinico Universitario Campus Bio Medico".
undefined are not yet recruiting,
16 are recruiting,
19 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 40 completed trials in Policlinico Universitario Campus Bio Medico,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Policlinico Universitario Campus Bio Medico, 3 "Phase 1"
clinical trials were conducted, 37 "Phase 2" clinical
trials and 26 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 11 trials that are defined as “Not Applicable".
Departments of Policlinico Universitario Campus Bio Medico
Policlinico Universitario Campus Bio Medico has several departments that took part in Clinical trials: "Divisione Ematologia - Università Campus Bio-Medico" - 12 trials, "Policlinico Universitario Campus Biomedico; Uoc Oncologia Medica" - 12 trials, "Campus Biomedico - Cardiologia" - 4 trials, "Institute of Neurology, Campus Biomedico University" - 3 trials
Departments List